Latest News
Cresset, a UK-based developer of drug discovery and design software, has secured a significant investment from Scottish Equity Partners (SEP), a technology focused growth equity firm.
With this investment, Cresset will accelerate its drive for exceptional talent to continue broadening the science platform. Additionally, the funding will be used to expand operations internationally, particularly in the US.
Cresset’s computational methods enable its customers to accelerate drug discovery workflows by predicting molecular interactions and enabling prioritisation of drug candidates. Its computer-aided drug discovery (CADD) solutions are used by research chemists globally, including in 8 of the top 10 pharma companies.
Cresset’s
Clearlake Capital Group, an investment firm founded in 2006 operating integrated businesses across private equity, credit and other related strategies, has completed fundraising for Clearlake Opportunities Partners III (COP III) with more than $2.5 billion in capital commitments.
COP III was oversubscribed (including commitments from the General Partner and affiliates) and exceeded its $1.5 billion target with support from existing and new limited partners.
COP III will continue Clearlake’s flexible investment strategy of investing in non-control special situations investments, utilising the Firm’s sector-focused approach targeting investments in technology, industrial, and consumer businesses.
Limited partners in COP III include
Avanta Ventures, the venture capital arm of CSAA Insurance Group, has raised $225 million for its early-stage Fund II, bringing assets under management to over $300 million.
Avanta Ventures’ primary investment focus is insurtech, mobility, and risk-adjacent sectors such as fintech, cybersecurity, smart home, and applied artificial intelligence. Avanta Ventures invests $1 million-$10 million in early-stage companies at the Seed, Series A and Series B stages, with the ability to lead deals, while also reserving significant capital for follow-on investment to continue to support its portfolio.
Avanta Ventures’ investment team brings 50-plus years of combined venture capital and entrepreneurial operating
Arctos Sports Partners, a private investment platform dedicated to providing growth capital and liquidity solutions to professional sports franchise owners in major North American leagues and premier global sports organisations, has appointed Shane Battier, Jessica Gelman, Chris Grove and Normand Legault as operating advisors.
Arctos’ group of operating advisers brings deep operational experience and perspective to the firm and is a valuable resource for Arctos’ portfolio franchises and investment team.
The firm’s operating advisors play a broad role in the firm’s operations, including identifying and completing due diligence on potential investments, providing insights into industry trends and deepening relationships with
Ara Partners (Ara), a private equity firm specialising in industrial decarbonisation investments, has appointed David Touhey s Managing Director of the firm’s Portfolio Services Group. Touhey has more than 20 years of experience in project development and optimisation in the industrial sector.
Prior to joining Ara, Touhey was the Executive Vice President for Kent, a global EPC, operations, and maintenance business. At Kent, he was a key member of the executive team that grew the organisation from 4,000 people across 19 countries to 12,500 people across 26 countries.
During his time at Kent, Touhey was the executive sponsor and trusted advisor
All Seas Capital Fund I (All Seas Capital), a pan-European private capital fund that provides transformational capital solutions to founder- and entrepreneur-owned companies, has made a significant minority investment in Zimmer MedizinSysteme (Zimmer), a manufacturer of physiotherapy and aesthetics devices.
A German family run business with over 50 years’ experience, Zimmer has grown into its position today as a European leader in the design, manufacturing and distribution of best-in-class medical devices for the physiotherapy, aesthetics, and select diagnostics fields. The Company operates in over 110 countries with c540 employees and is represented worldwide by 19 sales and production sites and
Drawbridge, a provider of cybersecurity software and solutions to the alternative investment industry, has completed its SOC 2 Type II audit, performed by KirkpatrickPrice.
KKR and the Hero Group have signed a deal to invest $450 million in Hero Future Energies (HFE), the renewable energy arm of the Hero Group. This investment will position HFE for continued growth and support its efforts to expand its renewable energy capacity and capabilities across technologies such as solar, wind, battery storage, and green hydrogen, and into new markets over time.
Founded in 2012, Hero Future Energies is a leading independent power producer (IPP) in India with a diversified portfolio of 1.6 GW of operating solar and wind projects.
Beyond supporting HFE’s growth, this round of investment led
Neuberger Berman, a private, independent, employee-owned investment manager, has held the final close of NB Secondary Opportunities Fund V LP (SOF V), the firm’s fifth global private equity secondary fund at $4.9 billion, surpassing its target of $3.0 billion.
Mirova has raised €1.6 billion for the Mirova Energy Transition 5 (MET 5), its fifth energy transition infrastructure equity fund.
This historic fundraising round, which lasted 18 months, is testament to the hard work of Mirova’s teams, who have been active in the energy transition infrastructure sector for 20 years. The team launched their first fund of €46 million in 2002 alongside ADEME to kick-start the wind energy sector in France. It then raised two further funds of €94 million in 2008 and €354 million in 2014 to open up to new geographies and technologies. Finally, the fourth fund
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
